Life Sciences

Life sciences consulting from Brillio helps pharmaceutical companies advance innovation through AI and machine learning amid rising complexity in regulations, research, and data. Organizations have achieved 40% ROI, 30% faster user provisioning, and 75% reduction in false positives through these strategic services. The consulting accelerates research and development to deliver improved patient outcomes across pharmaceuticals, medical devices, and digital health ecosystems.

AI enables breakthroughs in personalized medicine and AI-driven drug discovery by delivering faster, more reliable, and more compliant outcomes for life sciences organizations. Brillio’s AI consulting services help companies leverage Gen AI and cutting-edge solutions to lead digital disruptions in Healthcare & Life Sciences. These technologies accelerate research timelines while improving accuracy in drug development processes.

Brillio’s life sciences digital transformation focuses on four segments: Pharmaceutical (accelerating R&D for improved patient outcomes), Medical Devices (turning data into assets), Digital Health & Products (building scalable patient-centric solutions), and Intermediaries (creating frameworks for stakeholders in medical research and clinical trials). This comprehensive approach addresses the entire healthcare value chain from drug development to patient engagement.

Digital health solutions from Brillio enhance patient experience through specialized capabilities including mobile health applications, telehealth and telemedicine, and healthcare AI chatbots. These services also encompass Omnichannel Patient Engagement and IoT-enabled data strategy and analytics. The solutions drive patient and HCP-focused initiatives that revolutionize well-being management and foster a secure, collaborative healthcare ecosystem.

Clinical trial digitalization services from Brillio utilize advisory, digital engineering, AI, analytics, and automation to streamline processes from patient consent to data exchange. Smart clinical trials solutions provide digital tools for instant access, quality oversight, virtual trials, and data strategies. Organizations achieve reduced clinical trial simulations cycle time along with enriched experience for clinical staff and improved governance.

Life sciences companies working with Brillio have achieved 40% ROI, 30% faster user provisioning, and 75% reduction in false positives through digital transformation initiatives. Additional benefits include enriched experience for clinical staff, optimized performance, improved governance, and reduced clinical trial simulations cycle time. These outcomes span pharmaceuticals, medical devices, and digital health ecosystems.

Medical device innovation services from Brillio leverage wireless, IoT, and AI/ML health devices to improve diagnosis, treatment, and patient care. The engineering expertise delivers cutting-edge connected healthcare solutions that adapt to trends and expedite R&D. These technologies enable medical devices organizations to turn data into assets and devices into holistic solutions for better clinical outcomes.

Smart clinical trials solutions provide research organizations with streamlined processes using digital tools for instant access, quality oversight, and virtual trials capabilities. Organizations benefit from reduced clinical trial simulations cycle time, improved governance, and optimized performance. The solutions integrate advisory, analytics, and automation to enhance clinical research from patient consent through data exchange.